loading
Schlusskurs vom Vortag:
$18.11
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$149.05M
KGV:
0.00
EPS:
1.9846
Netto-Cashflow:
$-6.05M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-96.95%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$19.00

Galera Therapeutics Inc Stock (GRTX) Company Profile

Name
Firmenname
Galera Therapeutics Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-18
Name
Neueste SEC-Einreichungen
Name
GRTX's Discussions on Twitter

Compare GRTX vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
GRTX icon
GRTX
Galera Therapeutics Inc
0.00 0 0 149.05M -6.05M 1.9846
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
550.35 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
821.56 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,047.58 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
149.47 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
203.20 45.38B 742.00K -1.37B -1.07B -7.0731

Galera Therapeutics Inc Stock (GRTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-10 Herabstufung Piper Sandler Overweight → Neutral
2021-10-19 Herabstufung BTIG Research Buy → Neutral
2021-10-19 Herabstufung BofA Securities Buy → Underperform
2021-04-26 Fortgesetzt Credit Suisse Outperform
2020-12-16 Hochstufung Credit Suisse Neutral → Outperform
2020-12-07 Eingeleitet H.C. Wainwright Buy
2019-12-02 Eingeleitet BTIG Research Buy
2019-12-02 Eingeleitet BofA/Merrill Buy
2019-12-02 Eingeleitet Citigroup Buy
2019-12-02 Eingeleitet Credit Suisse Neutral
Alle ansehen

Galera Therapeutics Inc Aktie (GRTX) Neueste Nachrichten

pulisher
Aug 19, 2026

Obsidian Therapeutics Merges with Galera Therapeutics - Labroots

Aug 19, 2026
pulisher
Aug 14, 2026

Ikarian Capital (GRTX) reports 0% beneficial ownership of Galera Therapeutics in 13G/A amendment - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Obsidian Therapeutics (OBX) boosts cash with $350M PIPE and Galera merger - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Obsidian Therapeutics (OBX) outlines $350M PIPE, Galera mergers and CVR structure - Stock Titan

Aug 14, 2026
pulisher
Aug 10, 2026

Galera Therapeutics, Inc. SEC Filing (Aug 10, 2026) - Stock Titan

Aug 10, 2026
pulisher
Aug 05, 2026

Galera Therapeutics (GRTX) CEO reports option and share disposition tied to merger - Stock Titan

Aug 05, 2026
pulisher
Aug 05, 2026

Galera Therapeutics, Inc. (GRTX) details director option change - Stock Titan

Aug 05, 2026
pulisher
Aug 05, 2026

Galera Therapeutics (NASDAQ: GRTX) details conversions tied to Obsidian merger - stocktitan.net

Aug 05, 2026
pulisher
Aug 05, 2026

Galera Therapeutics (NASDAQ: GRTX) director’s options converted in merger - Stock Titan

Aug 05, 2026
pulisher
Aug 05, 2026

Galera Therapeutics (GRTX) CAO exits 10,000 stock options in merger - Stock Titan

Aug 05, 2026
pulisher
Aug 05, 2026

Galera Therapeutics (GRTX) director details merger-driven stock and option moves - stocktitan.net

Aug 05, 2026
pulisher
Aug 05, 2026

Obsidian Therapeutics’ Nasdaq Listing via Galera Reverse Merger Yields 170% Gain to RTW Bio’s Valuation - Kalkine Media

Aug 05, 2026
pulisher
Aug 04, 2026

Galera Therapeutics, Inc. SEC Filing (Aug 4, 2026) - Stock Titan

Aug 04, 2026
pulisher
Aug 04, 2026

GALERA THERAPEUTICS, INC : PIPER SANDLER INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $42 - Bitget

Aug 04, 2026
pulisher
Aug 04, 2026

Obsidian Therapeutics Completes Merger and Leadership Transition - TipRanks

Aug 04, 2026
pulisher
Aug 04, 2026

Galera Therapeutics Completes Merger with Obsidian Therapeutics and Becomes Obsidian Therapeutics, Inc - Minichart

Aug 04, 2026
pulisher
Aug 04, 2026

Galera Therapeutics, Inc. Announces Resignation of Joel Sussman as the Principal Financial and Accounting Officer - marketscreener.com

Aug 04, 2026
pulisher
Aug 04, 2026

Galera (NASDAQ: GRTX) closes Obsidian merger, sets 80%/95% CVRs - Stock Titan

Aug 04, 2026
pulisher
Aug 03, 2026

Galera Therapeutics, Inc. (GRTXD) Latest Press Releases & Corporate News - Yahoo! Finance Canada

Aug 03, 2026
pulisher
Aug 03, 2026

Obsidian Completes Galera Merger with $350M Private Placement Financing - Contract Pharma

Aug 03, 2026
pulisher
Aug 03, 2026

Obsidian Therapeutics completes merger with Galera By Investing.com - Investing.com Nigeria

Aug 03, 2026
pulisher
Aug 03, 2026

Obsidian Therapeutics Completes Galera Merger and $350 Million Financing - citybiz

Aug 03, 2026
pulisher
Aug 03, 2026

Obsidian Therapeutics completes merger with Galera - Investing.com

Aug 03, 2026
pulisher
Jul 31, 2026

Galera Therapeutics Announces Major PIPE Financing and CVRs - tipranks.com

Jul 31, 2026
pulisher
Jul 24, 2026

Galera Therapeutics, Inc. (GRTXD) Stock Price, News, Quote & History - Yahoo Finance

Jul 24, 2026
pulisher
Jul 24, 2026

GRTXD Interactive Stock Chart | Galera Therapeutics, Inc. Stock - Yahoo Finance

Jul 24, 2026
pulisher
Jul 24, 2026

Galera Therapeutics, Inc. (GRTXD) insider ownership and holdings - Yahoo Finance Singapore

Jul 24, 2026
pulisher
Jul 24, 2026

Galera Therapeutics, Inc. (GRTXD) - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Galera Therapeutics, Inc. (GRTXD) Company Profile & Facts - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Galera Therapeutics, Inc. (GRTXD) Stock Major Holders - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Galera Therapeutics, Inc. (GRTXD) Stock Forum & Discussion - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 23, 2026

GRTXD: Galera TherapeuticsInsider Transations - Zacks Investment Research

Jul 23, 2026
pulisher
Jul 17, 2026

Galera Therapeutics (GRTXD) Pe Ratio (TTM) - Zacks Investment Research

Jul 17, 2026
pulisher
Jul 17, 2026

Gross profit of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 17, 2026
pulisher
Jul 16, 2026

Cost of goods sold of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

All News for GRTXD : Galera Therapeutics - Zacks Investment Research

Jul 16, 2026
pulisher
Jul 16, 2026

Cash flow from financing activities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

Cash flow from investing activities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

Free cash flow of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

Operating income of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

Non-controlling/minority interest of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 16, 2026
pulisher
Jul 15, 2026

Average basic shares outstanding of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Timothy Opler Net Worth (2026) - GuruFocus

Jul 15, 2026
pulisher
Jul 15, 2026

Net debt of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Total liabilities & shareholders' equities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

After tax other income/expense of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Total liabilities of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Total debt of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Galera Therapeutics, Inc. Cash Flow – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Galera Therapeutics, Inc. Balance Sheet – OTC:GRTXD - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Total revenue of Galera Therapeutics, Inc. – OTC:GRTXD - TradingView

Jul 15, 2026

Finanzdaten der Galera Therapeutics Inc-Aktie (GRTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$122.26
price down icon 1.35%
$62.01
price down icon 0.12%
$111.68
price down icon 2.08%
$239.62
price up icon 0.03%
ONC ONC
$374.13
price down icon 0.55%
$204.18
price down icon 2.57%
Kapitalisierung:     |  Volumen (24h):